Endovascular Engineering
United States, Menlo Park, California
About Endovascular Engineering
Creating innovative venous thrombectomy solutions. | Endovascular Engineering, Inc. ("E2"), is a mission driven, venture-backed company focusing on the development and deployment of groundbreaking clot removal technologies that target venous thromboembolism.
Latest Funding
Series C+Announced 2026-04-07
Buying Signals
Where the capital is going, and whether it's already started moving.
Spend Intent
5 signals · where the capital is going
Expand manufacturing and operations capacity for commercial rollout
founder_quote
Commercialize Hēlo Thrombectomy Platform for pulmonary embolism treatment
press_release
+3 more capital deployment signals · confidence ratings · source articles
Sign up freeIn the news
Selling to Endovascular Engineering? You're in the right place.
Knowing they raised is the start. The edge is what's attached to Endovascular Engineering.
Spend intent
Where this round will be spent.
Hiring signals
Which departments are growing.
Verified contacts
Who actually decides.
No credit card. Five minutes, no approvals.
Ask AI
What is the unique value proposition of Endovascular Engineering, and who are their main competitors?
Sign up free to ask AI about Endovascular Engineering
Our AI has read their website, news, and funding history. 25 credits included with every free account.
Sign up free: 25 credits includedAuto-matched to your ICP
Every company, scored against your profile. Automatically.
Industry
High
Size
Mid
Stage
High
Match score blends industry, company size, growth stage, tech stack, and geography. The moment you set your ICP, every company in our database gets scored.
Investors
Gilde Healthcare
Lead investor · Series C+
Tech Stack
Google Analytics
Site Kit
Apache HTTP Server
Key Highlights
AI InsightsInvestments in R&D and operations expansion
AI reads their website, press releases, and funding context to surface what makes them unique - so you tailor your pitch before the first call.
Try it free →Generates a personalized cold email based on their funding round, capital deployment signals, and company context. Ready to send in under 10 seconds.
Try it free →Short, personalized connection request crafted around their recent funding and what your product can help them achieve with it.
Try it free →Maps their competitive landscape with AI - invaluable context before your first call and for positioning your pitch against their alternatives.
Try it free →Extracts capital deployment signals from their funding news - reach out knowing exactly where they're investing and why your product fits.
Try it free →Similar Companies
Discover companies similar to Endovascular Engineering
Selling to Endovascular Engineering? You're in the right place.
Knowing they raised is the start. Our difference is what comes attached to Endovascular Engineering.
Spend Intent
Where this round will be spent.
Hiring Signals
Which departments are growing.
Verified Contacts
Who actually decides.
No credit card. Five minutes, no approvals.
Free weekly newsletter on startup funding.
20 rounds, ranked by amount. Industry and stage breakdowns. A short market note. One email, free, no noise. 2,000+ subscribers.
No spam, ever. Unsubscribe with one click.